Sequana Medical Forecast, price target & analysts
Sequana Medical Target price 2025 - Analyst rating & recommendation
Sequana Medical Classifications & Recommendation:
Sequana Medical Price Target
| Target Price | €4.08 |
| Price | €1.39 |
| Potential |
193.10%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Sequana Medical 2026 .
The average Sequana Medical target price is €4.08.
This is
193.10%
register free of charge
€5.25
277.16%
register free of charge
€2.93
110.42%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend Sequana Medical to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sequana Medical stock has an average upside potential 2026 of
193.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 0.11 | 0.88 |
| 84.51% | 695.91% | |
| EBITDA Margin | -16,009.09% | -2,235.29% |
| 303.07% | 86.04% | |
| Net Margin | -40,590.91% | -1,341.93% |
| 785.12% | 96.69% |
5 Analysts have issued a sales forecast Sequana Medical 2025 . The average Sequana Medical sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Sequana Medical EBITDA forecast 2025. The average Sequana Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Sequana Medical Analysts have issued a net profit forecast 2025. The average Sequana Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | -1.22 | -0.26 |
| 0.00% | 78.69% | |
| P/E | negative | |
| EV/Sales | 135.85 |
6 Analysts have issued a Sequana Medical forecast for earnings per share. The average Sequana Medical EPS is
This results in the following potential growth metrics and future valuations:
Sequana Medical...
Current Sequana Medical Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | May 26 2025 |
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
| DEGROOF PETERCAM |
Locked
➜
Locked
|
Locked | Dec 22 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
May 26 2025 |
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
Mar 17 2025 |
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Dec 23 2024 |
|
Locked
DEGROOF PETERCAM:
Locked
➜
Locked
|
Dec 22 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
